[1]Neus Thwander Tetri BA.Nomalchodic Steatohepatitis and the meta-bolic syndrome[J].Am J medsci, 2005, 330:326-335.
|
[2]罗益民, 曾民德.非酒精性脂肪肝及酒精性脂肪肝病的药物治疗研究进展及临床实验设计[J].肝脏, 2006, 11 (6) :437.
|
[3] 中华医学会肝脏病分会脂肪肝和酒精性肝病学组.非酒精性脂肪肝病诊疗指南[J].中华医学杂志, 2006, 14 (3) :62.
|
[4]Lin Hz, Yang So, Chackarac C, et al.Metfornin reuerses fatly liver disease in obese leptin-chejicient Micc[J].nat mad, 2000, 6:995-1003.
|
[5]Jokelainen K.Reinke LA.Nanji A A, et al.NF-KB activation is activated with free radical generation and endoxermia procedes patho-togical liver injure in experimental alcoholic liver elisease[J].cyto-kine, 2001, 16 (1) :36-39.
|
[6]Waris G, Huhk W.Siddiqui A, et al.Mitochondrially Asociated B virus x pratein constitutively activates transcription factors stats and NF-KB Via oxidatise stress[J].Mol cell Biol, 2001, 21 (22) :7721-7730.
|
[7]赵彩彦, 王亚东, 周俊, 等.罗格列酮对大鼠非酒精性脂肪性肝炎逆转机制的研究[J].中华肝病杂志, 2007, 15 (6) :450-454.
|
[8]崔克勤, 赵翔伟.罗格列酮治疗非酒精性脂肪肝的疗效与脂联素相关[J].世界华人消化杂志, 2006, 14 (13) :1326-1329.
|
[9]第57届美国肝病学会年会纪要[J].中华肝脏病杂志, 2006, 14 (12) :949.
|
[10]黄一鑫.脂联素研究现状[J].医学综述, 2004, 10 (10) :591.
|
[11]Wasselli JR.Behevioral and liological determints of leptin resistance[J].Appitile, 2001, 37:115-117.
|
[12]张学武, 周敏.熊去氧胆酸联合护肝片治疗非酒精性脂肪性肝炎[J].中西医结合肝病杂志, 2003, 13 (1) :19.
|
[13]方继伟, 范建高.非酒精性脂肪肝的治疗现状[J].中华肝脏病杂志, 2003, 11 (2) :120-122.
|
[14]陈黎, 涂燕云, 林海, 等.血脂康治疗NAFLD病合并高脂血症48例[J].中西医结合肝病杂志, 2006, 16 (2) :112.
|
[15]林宏.降脂柔肝汤治疗脂肪肝68例[J].中西医结合肝病杂志, 2003, 13 (5) :301.
|
[16]陈晋源, 康永.活血降脂胶囊治疗非酒精性脂肪肝48例[J].中西医结合肝病杂志, 2006, 16 (2) :114-115.
|
[17]杨海棠, 杨志勇, 向仁义, 等.益肝降脂胶囊治疗非酒精性脂肪肝68例[J].中西医结合肝病杂志, 2007, 17 (1) :56.
|